GPT Healthcare Limited — PPTs, 14-11-2024: Investor Presentation

### Financial Highlights

GPT Healthcare has reported strong revenue from operations of Rs 105.7 Cr for Q2 FY25, with an EBITDA of Rs 26.3 Cr, yielding a margin of 24.4%. The PAT reached Rs 14.8 Cr, reflecting a margin of 13.8%. For H1 FY25, total income stood at Rs 208.5 Cr, with a PAT of Rs 24.7 Cr (11.9% margin), showing a 5.2% increase YoY. The average revenue per occupied bed (ARPOB) improved to Rs 36,676, alongside a decrease in average length of stay (ALOS) to 3.51 days.

### Strategic Initiatives and Growth Drivers

Further, GPT Healthcare is expanding its operational capacity with new offerings such as a cancer care department in Agartala Hospital and plans to ramp up occupancy rates across other facilities. The introduction of cutting-edge surgical technology at the Salt Lake Hospital and orthopedics at Howrah Hospital demonstrates their commitment to enhancing service quality.

### Business Developments

Significant investments are being made, including plans for setting up a new hospital in Raipur, Chhattisgarh, estimated at Rs 55 Cr, expected to start operations in Q4 FY25. The development of a healthcare mobile app aims to improve patient interaction and service accessibility.

### Market Position and Competitive Advantage

With four multispecialty hospitals located strategically in densely populated areas, GPT Healthcare maintains a competitive advantage through strong community engagement and brand reputation. Consistent occupancy and margin performance affirm their robust operational model.

### Investor Implications

The promising growth trajectory and focus on strategic expansions position GPT Healthcare well for future growth, suggesting a positive outlook for investors willing to monitor developments closely.